Forbes - SAN MATEO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel management therapies, announced today that Anthony DiTonno, Chief Executive Officer ...
- Recent posts
- California Pain Management LL3053
- World's First FDA-Cleared Combination Therapeutic Laser and TENS Unit ...
- NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
- Anti-Depressants Bad For Pain, Make Case For Medical Marijuana
- Front Desk Postition for growing pain management practice,
- Website Dedicated To Reversing Back Pain Launched
- Xanodyne Announces Two Senior Appointments
- Technology assists self-care for chronic pain
- Anna Nicole's Deadly Drug Cocktail: Is a Doctor to Blame?
- Implantable technology for pain management
- How Naked Mole Rats Beat Chili Pepper Heat
- An Observational Study of Oncology Patients' Utilization of ...
- Journal of Opioid Management Welcomes New Editor-in-Chief!
- Sickle Cell Sufferers Face Uncommon Pain
- Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as ...
- When patients are partners
- Reporter Seeks Veterans and Pain Management
- Where Does It Hurt? - Health (washingtonian.com)
- Is epidural anesthesia truly the best pain management strategy ...
- New Survey Finds Majority of Americans in Pain; Acute Pain Sufferers ...